HHMI
LXRX icon

Howard Hughes Medical Institute’s Lexicon Pharmaceuticals LXRX Stock Holding History

Howard Hughes Medical Institute’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-51,520
Closed -$415K – 171
2015
Q2 		$415K Hold
51,520
– – 0.09% 103
2015
Q1 		$340K Hold
51,520
– – 0.05% 111
2014
Q4 		$328K Buy
+51,520
New +$415K 0.09% 113
2013
Q3 		– Sell
-19,504
Closed -$296K – 218
2013
Q2 		$296K Buy
+19,504
New +$296K 0.1% 76

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Howard Hughes Medical Institute's LXRX Position: Q3 2015 in Review

Howard Hughes Medical Institute sold out of Lexicon Pharmaceuticals (LXRX) in Q3 2015, closing a stake of 51,520 shares — an estimated $415K sold.

Howard Hughes Medical Institute first reported a position in LXRX in Q2 2013 and held it in 4 quarters. The position peaked at $415K in Q2 2015. 105 funds tracked by Wall St. Rank hold LXRX as of Q3 2015.

  • Howard Hughes Medical Institute reported no remaining Lexicon Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 51,520 Lexicon Pharmaceuticals shares in Q3 2015, an estimated $415K.
  • Howard Hughes Medical Institute first reported a position in Lexicon Pharmaceuticals in Q2 2013 and held it in 4 quarters.
  • Howard Hughes Medical Institute's Lexicon Pharmaceuticals position peaked at $415K in Q2 2015.
  • 105 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2015.

Based on Howard Hughes Medical Institute's 13F filing for Q3 2015, filed 16 Nov 2015.